Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionAssociated Banc-corp
Latest Disclosed Ownership7,274 shares
Latest Disclosed Value $ 1,111,102
Associated Banc-corp reports 0.16% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 1, 2026 - Associated Banc-corp filed a 13F-HR form disclosing ownership of 7,274 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $1,111,104 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 7,286 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -0.16% during the quarter. The current value of the position is $1,044,983 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,274 -12 -0.16 1,111 10.66 0.0294
2026-02-06 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,286 -70 -0.95 1,005 6.47 0.0257
2025-10-24 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,356 -745 -9.20 943 -3.78 0.0248
2025-08-12 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 8,101 -224 -2.69 980 5.60 0.0278
2025-05-09 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 8,325 -165 -1.94 928 12.35 0.0283
2025-02-10 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,490 -322 -3.65 826 -18.46 0.0249
2024-11-13 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,812 -40 -0.45 1,014 7.54 0.0298
2024-08-01 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 8,852 134 1.54 942 11.74 0.0293
2024-05-09 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 8,718 -103 -1.17 843 -5.28 0.0267
2024-02-09 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,821 -221 -2.44 891 -3.37 0.0309
2023-11-09 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 9,042 -240 -2.59 921 -1.60 0.0357
2023-08-07 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 9,282 -78 -0.83 937 8.71 0.0354
2023-05-09 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 9,360 185 2.02 861 3.49 0.0346
2023-02-10 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 9,175 27 0.30 832 19.71 0.0346
2022-11-09 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 9,148 -215 -2.30 695 -12.25 0.0321
2022-08-10 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 9,363 -431 -4.40 792 -7.80 0.0347
2022-05-11 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 9,794 -424 -4.15 859 -3.91 0.0331
2022-02-10 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 10,218 -125 -1.21 894 5.80 0.0328
2021-11-08 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 10,343 -356 -3.33 845 -13.51 0.0334
2021-08-11 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 10,699 -1,703 -13.73 977 -4.40 0.0387
2021-05-05 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 12,402 875 7.59 1,022 -6.07 0.0635
2021-02-11 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 11,527 -267 -2.26 1,088 6.15 0.0425
2020-11-12 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 11,794 -696 -5.57 1,025 -6.05 0.0441
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 12,490 -20 -0.16 1,091 5.82 0.0492
2020-05-14 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 12,510 1,070 9.35 1,031 -4.89 0.0549
2020-02-12 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 11,440 -115 -1.00 1,084 7.97 0.0540
2019-11-14 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 11,555 -654 -5.36 1,004 -9.96 0.0540
2019-08-06 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 12,209 -664 -5.16 1,115 -9.94 0.0611
2019-05-07 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 12,873 -190 -1.45 1,238 10.44 0.0714
2019-02-13 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 13,063 103 0.79 1,121 0.45 0.0731
2018-11-07 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 12,960 -9,972 -43.49 1,116 -35.57 0.0619
2018-08-07 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 22,932 -270 -1.16 1,732 -7.68 0.1013
2018-05-07 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 23,202 -1,738 -6.97 1,876 -10.41 0.1067
2018-02-07 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 24,940 -790 -3.07 2,094 -5.21 0.1129
2017-11-13 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 25,730 -1,671 -6.10 2,209 -3.41 0.1219
2017-08-10 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 27,401 -7,621 -21.76 2,287 -12.07 0.1297
2017-05-12 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 35,022 -784 -2.19 2,601 -0.27 0.1548
2017-02-10 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 35,806 -1,364 -3.67 2,608 -11.11 0.1628
2016-11-10 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 37,170 -492 -1.31 2,934 -5.57 0.1868
2016-08-11 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 37,662 5 0.01 3,107 13.89 0.1995
2016-05-12 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 37,657 -1,630 -4.15 2,728 -19.31 0.1792
2016-02-12 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 39,287 -439 -1.11 3,381 -7.42 0.2231
2015-11-10 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 39,726 -450 -1.12 3,652 -7.57 0.2548
2015-08-11 2015-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 40,176 -1,055 -2.56 3,951 -2.83 0.2533
2015-05-12 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 41,231 -1,283 -3.02 4,066 3.22 0.2566
2015-02-12 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 42,514 -3,400 -7.41 3,939 -8.86 0.2485
2014-11-05 2014-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 45,914 -306 -0.66 4,322 3.30 0.2837
2014-08-13 2014-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 46,220 -937 -1.99 4,184 4.37 0.2721
2014-05-13 2014-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 47,157 374 0.80 4,009 6.62 0.2765
2014-02-14 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 46,783 75 0.16 3,760 4.94 0.2700
2013-11-14 2013-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 46,708 -2,617 -5.31 3,583 2.72 0.2844
2013-08-13 2013-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 49,325 49,325 3,488 0.2866
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.